Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2012-04

AUTHORS

Kathryn A. Skelding, Richard D. Barry, Darren R. Shafren

ABSTRACT

Virotherapy is an emerging strategy for the treatment of cancer that utilizes both replication-competent and genetically modified viruses to selectively kill tumor cells. We have previously shown that Coxsackievirus A21 (CVA21), a common-cold producing enterovirus, is an effective oncolytic agent against human melanoma, prostate, and breast cancer xenografts in vivo. CVA21 specifically targets and lytically infects susceptible cells expressing the CVA21 cellular receptors, intercellular adhesion molecule-1 (ICAM-1) and decay-accelerating factor (DAF). Herein, the efficacy of CVA21 administered in combination with doxorubicin hydrochloride as a new therapeutic regimen for cancer was investigated. Flow cytometric analysis demonstrated that the human breast, colorectal, and pancreatic cancer cell lines examined expressed moderate levels of surface ICAM-1 and DAF, whilst a normal breast cell line expressed only minimal levels. When CVA21 was combined with doxorubicin hydrochloride, synergistically enhanced cell death was observed when CVA21 was administered both simultaneously or 24 h prior to doxorubicin hydrochloride exposure. Doxorubicin hydrochloride had no effect on CVA21 replication. Through the use of an orthotopic (MDA-MB-231-luc) xenograft SCID mouse model of human breast cancer we showed that a single intravenous injection of CVA21 in combination with an intraperitoneal injection of doxorubicin hydrochloride resulted in significantly greater tumor reduction compared to either agent alone. Overall, these findings highlight the exciting potential of CVA21, administered in combination with doxorubicin hydrochloride, as a new therapeutic regimen for cancer. More... »

PAGES

568-581

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10637-010-9614-0

DOI

http://dx.doi.org/10.1007/s10637-010-9614-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050938038

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/21170760


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibiotics, Antineoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CD55 Antigens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Death", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enterovirus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Flow Cytometry", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Injections, Intraperitoneal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Intercellular Adhesion Molecule-1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, SCID", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncolytic Virotherapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oncolytic Viruses", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tumor Burden", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Virus Internalization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, Discipline of Immunology and Microbiology, Faculty of Health, The University of Newcastle, David Maddison Clinical Sciences Building, 2300, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skelding", 
        "givenName": "Kathryn A.", 
        "id": "sg:person.0736435146.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736435146.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, Discipline of Immunology and Microbiology, Faculty of Health, The University of Newcastle, David Maddison Clinical Sciences Building, 2300, Newcastle, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barry", 
        "givenName": "Richard D.", 
        "id": "sg:person.01134100502.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134100502.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Newcastle Australia", 
          "id": "https://www.grid.ac/institutes/grid.266842.c", 
          "name": [
            "The Picornaviral Research Unit, Discipline of Immunology and Microbiology, Faculty of Health, The University of Newcastle, David Maddison Clinical Sciences Building, 2300, Newcastle, New South Wales, Australia", 
            "Viralytics Ltd, Suite 1B, 55-63 Grandview St, 2073, Pymble, New South Wales, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shafren", 
        "givenName": "Darren R.", 
        "id": "sg:person.0750717567.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750717567.49"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/0008-5472.can-05-2278", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000711759"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-008-9899-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006378409", 
          "https://doi.org/10.1007/s10549-008-9899-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-008-9899-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006378409", 
          "https://doi.org/10.1007/s10549-008-9899-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/sj.neo.7900016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010665418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci105166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011564784"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-007-0567-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011678892", 
          "https://doi.org/10.1007/s00280-007-0567-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-007-0567-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011678892", 
          "https://doi.org/10.1007/s00280-007-0567-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jviromet.2005.06.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013955766"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mlg.0b013e3181581977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019937880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mlg.0b013e3181581977", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019937880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.85.9.3095", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021032963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.soncn.2003.09.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021843687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.04.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026002664"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/77558", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026483107", 
          "https://doi.org/10.1038/77558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/77558", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026483107", 
          "https://doi.org/10.1038/77558"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pros.20741", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027350958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2007.05.027", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033064028"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-08-1088", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034525025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s002800050959", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035196448", 
          "https://doi.org/10.1007/s002800050959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2009.11.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036263198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djj111", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043017792"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-007-0313-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044998646", 
          "https://doi.org/10.1007/s00384-007-0313-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00384-007-0313-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044998646", 
          "https://doi.org/10.1007/s00384-007-0313-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.6-4-376", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046017180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(01)00486-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050999881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci104776", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052580026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-4598-8-47", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052739764", 
          "https://doi.org/10.1186/1476-4598-8-47"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-0690-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053385375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.2007.06550.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053722057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0022172400045228", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054798317"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/hum.2006.185", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059272974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.08.042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/ijo.26.6.1471", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071515724"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074750411", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074870435", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075019711", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1076050132", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077384838", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082404017", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082883031", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1996.14.8.2197", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082918702"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2012-04", 
    "datePublishedReg": "2012-04-01", 
    "description": "Virotherapy is an emerging strategy for the treatment of cancer that utilizes both replication-competent and genetically modified viruses to selectively kill tumor cells. We have previously shown that Coxsackievirus A21 (CVA21), a common-cold producing enterovirus, is an effective oncolytic agent against human melanoma, prostate, and breast cancer xenografts in vivo. CVA21 specifically targets and lytically infects susceptible cells expressing the CVA21 cellular receptors, intercellular adhesion molecule-1 (ICAM-1) and decay-accelerating factor (DAF). Herein, the efficacy of CVA21 administered in combination with doxorubicin hydrochloride as a new therapeutic regimen for cancer was investigated. Flow cytometric analysis demonstrated that the human breast, colorectal, and pancreatic cancer cell lines examined expressed moderate levels of surface ICAM-1 and DAF, whilst a normal breast cell line expressed only minimal levels. When CVA21 was combined with doxorubicin hydrochloride, synergistically enhanced cell death was observed when CVA21 was administered both simultaneously or 24\u00a0h prior to doxorubicin hydrochloride exposure. Doxorubicin hydrochloride had no effect on CVA21 replication. Through the use of an orthotopic (MDA-MB-231-luc) xenograft SCID mouse model of human breast cancer we showed that a single intravenous injection of CVA21 in combination with an intraperitoneal injection of doxorubicin hydrochloride resulted in significantly greater tumor reduction compared to either agent alone. Overall, these findings highlight the exciting potential of CVA21, administered in combination with doxorubicin hydrochloride, as a new therapeutic regimen for cancer.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10637-010-9614-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "30"
      }
    ], 
    "name": "Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride", 
    "pagination": "568-581", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "f2a6a708162f3abc46208ab379556fdb3fcff443ea368d0ac905e63c67cbcf4c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "21170760"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8309330"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10637-010-9614-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050938038"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10637-010-9614-0", 
      "https://app.dimensions.ai/details/publication/pub.1050938038"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:21", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000348_0000000348/records_54338_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10637-010-9614-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10637-010-9614-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10637-010-9614-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10637-010-9614-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10637-010-9614-0'


 

This table displays all metadata directly associated to this object as RDF triples.

287 TRIPLES      21 PREDICATES      89 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10637-010-9614-0 schema:about N0f2540a7410743bdb8cce36c66c6d6c9
2 N0f8da0c2556f498db0f080982d672cf1
3 N19f6f918c4ea4d67a1cbe7ac55b1619d
4 N1f1e4d42e15f4e98aacfcda1b2d80272
5 N27a60bb4aa934ec39ebb83717f96296f
6 N283ab8aa05a449708fff1e37cea280e8
7 N36893cd1b4dc423d9233d4effbe3e7eb
8 N3a06da277e2c4a4c9181febc5918dca4
9 N3f47753f71a048cea70919038c3bffe1
10 N5ef430cbca2c49f2b02efc525ab561ee
11 N7e18c6a1eaeb46c8b34044fcabcda62e
12 N806dd7728b564c379b3f50af852c30bd
13 N8ca524300bc04e5bb2476b265a557144
14 N98273fb83ad34f61b879be3a98dca017
15 Na1dd8c8799fc4032bf4b98c4e99d975d
16 Na47483c4a37545bfb95a169114a61789
17 Na764c0a2a6f345e7962eaf21b3ef14c8
18 Naa0b10d080604f8fba08d9b069f6b346
19 Ncb4eac4aa7c24448940fce1f55874fe7
20 Nccf38f1145584861b5ef3193be88fec3
21 Nd7600fabf1ed4dc8841124dff798d810
22 Nd7ee708beb0b418a9ec455047020449f
23 Ndd2c3e2d47ba4a9893d77388f77bb4e6
24 Nf01e0c0eb3ce4fbd9da2d8c95f349e4c
25 anzsrc-for:11
26 anzsrc-for:1112
27 schema:author N0a8ff04a165d43df909a8e54cf8f965c
28 schema:citation sg:pub.10.1007/s00280-007-0567-8
29 sg:pub.10.1007/s002800050959
30 sg:pub.10.1007/s00384-007-0313-z
31 sg:pub.10.1007/s10549-008-9899-2
32 sg:pub.10.1038/77558
33 sg:pub.10.1186/1476-4598-8-47
34 https://app.dimensions.ai/details/publication/pub.1074750411
35 https://app.dimensions.ai/details/publication/pub.1074870435
36 https://app.dimensions.ai/details/publication/pub.1075019711
37 https://app.dimensions.ai/details/publication/pub.1076050132
38 https://app.dimensions.ai/details/publication/pub.1077384838
39 https://app.dimensions.ai/details/publication/pub.1082404017
40 https://app.dimensions.ai/details/publication/pub.1082883031
41 https://doi.org/10.1002/pros.20741
42 https://doi.org/10.1016/j.bbrc.2007.05.027
43 https://doi.org/10.1016/j.ejca.2009.11.005
44 https://doi.org/10.1016/j.jviromet.2005.06.016
45 https://doi.org/10.1016/s1470-2045(01)00486-7
46 https://doi.org/10.1017/s0022172400045228
47 https://doi.org/10.1038/sj.neo.7900016
48 https://doi.org/10.1053/j.soncn.2003.09.004
49 https://doi.org/10.1073/pnas.85.9.3095
50 https://doi.org/10.1089/hum.2006.185
51 https://doi.org/10.1093/jnci/djj111
52 https://doi.org/10.1097/mlg.0b013e3181581977
53 https://doi.org/10.1111/j.1365-2141.2007.06550.x
54 https://doi.org/10.1158/0008-5472.can-05-2278
55 https://doi.org/10.1158/1078-0432.ccr-0690-3
56 https://doi.org/10.1158/1078-0432.ccr-08-1088
57 https://doi.org/10.1172/jci104776
58 https://doi.org/10.1172/jci105166
59 https://doi.org/10.1200/jco.1996.14.8.2197
60 https://doi.org/10.1200/jco.2002.08.042
61 https://doi.org/10.1200/jco.2004.04.024
62 https://doi.org/10.1634/theoncologist.6-4-376
63 https://doi.org/10.3892/ijo.26.6.1471
64 schema:datePublished 2012-04
65 schema:datePublishedReg 2012-04-01
66 schema:description Virotherapy is an emerging strategy for the treatment of cancer that utilizes both replication-competent and genetically modified viruses to selectively kill tumor cells. We have previously shown that Coxsackievirus A21 (CVA21), a common-cold producing enterovirus, is an effective oncolytic agent against human melanoma, prostate, and breast cancer xenografts in vivo. CVA21 specifically targets and lytically infects susceptible cells expressing the CVA21 cellular receptors, intercellular adhesion molecule-1 (ICAM-1) and decay-accelerating factor (DAF). Herein, the efficacy of CVA21 administered in combination with doxorubicin hydrochloride as a new therapeutic regimen for cancer was investigated. Flow cytometric analysis demonstrated that the human breast, colorectal, and pancreatic cancer cell lines examined expressed moderate levels of surface ICAM-1 and DAF, whilst a normal breast cell line expressed only minimal levels. When CVA21 was combined with doxorubicin hydrochloride, synergistically enhanced cell death was observed when CVA21 was administered both simultaneously or 24 h prior to doxorubicin hydrochloride exposure. Doxorubicin hydrochloride had no effect on CVA21 replication. Through the use of an orthotopic (MDA-MB-231-luc) xenograft SCID mouse model of human breast cancer we showed that a single intravenous injection of CVA21 in combination with an intraperitoneal injection of doxorubicin hydrochloride resulted in significantly greater tumor reduction compared to either agent alone. Overall, these findings highlight the exciting potential of CVA21, administered in combination with doxorubicin hydrochloride, as a new therapeutic regimen for cancer.
67 schema:genre research_article
68 schema:inLanguage en
69 schema:isAccessibleForFree false
70 schema:isPartOf N590566ed852f465f8ebdff6563793867
71 Nc5ad910d98364a4681b0a8fd0c47a969
72 sg:journal.1094201
73 schema:name Enhanced oncolysis mediated by Coxsackievirus A21 in combination with doxorubicin hydrochloride
74 schema:pagination 568-581
75 schema:productId N15a3315cb3d747f7a7dcdcd65b32d60d
76 N7386fb5c1564453db333d65417cb5172
77 Na3a4a5dd77224126aed1e5910ec33e86
78 Nafd3a96ad72b4f5f9b98a3c2967c81ab
79 Nba388ad1604c436aa3e75f35b54b30d0
80 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050938038
81 https://doi.org/10.1007/s10637-010-9614-0
82 schema:sdDatePublished 2019-04-11T10:21
83 schema:sdLicense https://scigraph.springernature.com/explorer/license/
84 schema:sdPublisher N77aaf401a88540d4a55990e04bb9616c
85 schema:url https://link.springer.com/10.1007%2Fs10637-010-9614-0
86 sgo:license sg:explorer/license/
87 sgo:sdDataset articles
88 rdf:type schema:ScholarlyArticle
89 N0a8ff04a165d43df909a8e54cf8f965c rdf:first sg:person.0736435146.19
90 rdf:rest N244f7648674d4e9dad54ddee27095f7c
91 N0f2540a7410743bdb8cce36c66c6d6c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Cell Cycle
93 rdf:type schema:DefinedTerm
94 N0f8da0c2556f498db0f080982d672cf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Enterovirus
96 rdf:type schema:DefinedTerm
97 N15a3315cb3d747f7a7dcdcd65b32d60d schema:name readcube_id
98 schema:value f2a6a708162f3abc46208ab379556fdb3fcff443ea368d0ac905e63c67cbcf4c
99 rdf:type schema:PropertyValue
100 N19f6f918c4ea4d67a1cbe7ac55b1619d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Oncolytic Viruses
102 rdf:type schema:DefinedTerm
103 N1f1e4d42e15f4e98aacfcda1b2d80272 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Intercellular Adhesion Molecule-1
105 rdf:type schema:DefinedTerm
106 N244f7648674d4e9dad54ddee27095f7c rdf:first sg:person.01134100502.12
107 rdf:rest N857d29d18b6249038924b521cb0cae4e
108 N27a60bb4aa934ec39ebb83717f96296f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Female
110 rdf:type schema:DefinedTerm
111 N283ab8aa05a449708fff1e37cea280e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Mice
113 rdf:type schema:DefinedTerm
114 N36893cd1b4dc423d9233d4effbe3e7eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Doxorubicin
116 rdf:type schema:DefinedTerm
117 N3a06da277e2c4a4c9181febc5918dca4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Dose-Response Relationship, Drug
119 rdf:type schema:DefinedTerm
120 N3f47753f71a048cea70919038c3bffe1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Mice, SCID
122 rdf:type schema:DefinedTerm
123 N590566ed852f465f8ebdff6563793867 schema:volumeNumber 30
124 rdf:type schema:PublicationVolume
125 N5ef430cbca2c49f2b02efc525ab561ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name CD55 Antigens
127 rdf:type schema:DefinedTerm
128 N7386fb5c1564453db333d65417cb5172 schema:name dimensions_id
129 schema:value pub.1050938038
130 rdf:type schema:PropertyValue
131 N77aaf401a88540d4a55990e04bb9616c schema:name Springer Nature - SN SciGraph project
132 rdf:type schema:Organization
133 N7e18c6a1eaeb46c8b34044fcabcda62e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Animals
135 rdf:type schema:DefinedTerm
136 N806dd7728b564c379b3f50af852c30bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Oncolytic Virotherapy
138 rdf:type schema:DefinedTerm
139 N857d29d18b6249038924b521cb0cae4e rdf:first sg:person.0750717567.49
140 rdf:rest rdf:nil
141 N8ca524300bc04e5bb2476b265a557144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Flow Cytometry
143 rdf:type schema:DefinedTerm
144 N98273fb83ad34f61b879be3a98dca017 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Xenograft Model Antitumor Assays
146 rdf:type schema:DefinedTerm
147 Na1dd8c8799fc4032bf4b98c4e99d975d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Chemotherapy, Adjuvant
149 rdf:type schema:DefinedTerm
150 Na3a4a5dd77224126aed1e5910ec33e86 schema:name doi
151 schema:value 10.1007/s10637-010-9614-0
152 rdf:type schema:PropertyValue
153 Na47483c4a37545bfb95a169114a61789 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Cell Death
155 rdf:type schema:DefinedTerm
156 Na764c0a2a6f345e7962eaf21b3ef14c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Injections, Intraperitoneal
158 rdf:type schema:DefinedTerm
159 Naa0b10d080604f8fba08d9b069f6b346 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Virus Internalization
161 rdf:type schema:DefinedTerm
162 Nafd3a96ad72b4f5f9b98a3c2967c81ab schema:name nlm_unique_id
163 schema:value 8309330
164 rdf:type schema:PropertyValue
165 Nba388ad1604c436aa3e75f35b54b30d0 schema:name pubmed_id
166 schema:value 21170760
167 rdf:type schema:PropertyValue
168 Nc5ad910d98364a4681b0a8fd0c47a969 schema:issueNumber 2
169 rdf:type schema:PublicationIssue
170 Ncb4eac4aa7c24448940fce1f55874fe7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Neoplasms
172 rdf:type schema:DefinedTerm
173 Nccf38f1145584861b5ef3193be88fec3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Antibiotics, Antineoplastic
175 rdf:type schema:DefinedTerm
176 Nd7600fabf1ed4dc8841124dff798d810 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Tumor Burden
178 rdf:type schema:DefinedTerm
179 Nd7ee708beb0b418a9ec455047020449f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
180 schema:name Humans
181 rdf:type schema:DefinedTerm
182 Ndd2c3e2d47ba4a9893d77388f77bb4e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Time Factors
184 rdf:type schema:DefinedTerm
185 Nf01e0c0eb3ce4fbd9da2d8c95f349e4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Cell Line, Tumor
187 rdf:type schema:DefinedTerm
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
192 schema:name Oncology and Carcinogenesis
193 rdf:type schema:DefinedTerm
194 sg:journal.1094201 schema:issn 0167-6997
195 1573-0646
196 schema:name Investigational New Drugs
197 rdf:type schema:Periodical
198 sg:person.01134100502.12 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
199 schema:familyName Barry
200 schema:givenName Richard D.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134100502.12
202 rdf:type schema:Person
203 sg:person.0736435146.19 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
204 schema:familyName Skelding
205 schema:givenName Kathryn A.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0736435146.19
207 rdf:type schema:Person
208 sg:person.0750717567.49 schema:affiliation https://www.grid.ac/institutes/grid.266842.c
209 schema:familyName Shafren
210 schema:givenName Darren R.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0750717567.49
212 rdf:type schema:Person
213 sg:pub.10.1007/s00280-007-0567-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011678892
214 https://doi.org/10.1007/s00280-007-0567-8
215 rdf:type schema:CreativeWork
216 sg:pub.10.1007/s002800050959 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035196448
217 https://doi.org/10.1007/s002800050959
218 rdf:type schema:CreativeWork
219 sg:pub.10.1007/s00384-007-0313-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1044998646
220 https://doi.org/10.1007/s00384-007-0313-z
221 rdf:type schema:CreativeWork
222 sg:pub.10.1007/s10549-008-9899-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006378409
223 https://doi.org/10.1007/s10549-008-9899-2
224 rdf:type schema:CreativeWork
225 sg:pub.10.1038/77558 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026483107
226 https://doi.org/10.1038/77558
227 rdf:type schema:CreativeWork
228 sg:pub.10.1186/1476-4598-8-47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052739764
229 https://doi.org/10.1186/1476-4598-8-47
230 rdf:type schema:CreativeWork
231 https://app.dimensions.ai/details/publication/pub.1074750411 schema:CreativeWork
232 https://app.dimensions.ai/details/publication/pub.1074870435 schema:CreativeWork
233 https://app.dimensions.ai/details/publication/pub.1075019711 schema:CreativeWork
234 https://app.dimensions.ai/details/publication/pub.1076050132 schema:CreativeWork
235 https://app.dimensions.ai/details/publication/pub.1077384838 schema:CreativeWork
236 https://app.dimensions.ai/details/publication/pub.1082404017 schema:CreativeWork
237 https://app.dimensions.ai/details/publication/pub.1082883031 schema:CreativeWork
238 https://doi.org/10.1002/pros.20741 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027350958
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1016/j.bbrc.2007.05.027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033064028
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1016/j.ejca.2009.11.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036263198
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1016/j.jviromet.2005.06.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013955766
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1016/s1470-2045(01)00486-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050999881
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1017/s0022172400045228 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054798317
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1038/sj.neo.7900016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010665418
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1053/j.soncn.2003.09.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021843687
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1073/pnas.85.9.3095 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021032963
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1089/hum.2006.185 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059272974
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1093/jnci/djj111 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043017792
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1097/mlg.0b013e3181581977 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019937880
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1111/j.1365-2141.2007.06550.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053722057
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1158/0008-5472.can-05-2278 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000711759
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1158/1078-0432.ccr-0690-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053385375
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1158/1078-0432.ccr-08-1088 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034525025
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1172/jci104776 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052580026
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1172/jci105166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011564784
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1200/jco.1996.14.8.2197 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082918702
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1200/jco.2002.08.042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203069
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1200/jco.2004.04.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026002664
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1634/theoncologist.6-4-376 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046017180
281 rdf:type schema:CreativeWork
282 https://doi.org/10.3892/ijo.26.6.1471 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071515724
283 rdf:type schema:CreativeWork
284 https://www.grid.ac/institutes/grid.266842.c schema:alternateName University of Newcastle Australia
285 schema:name The Picornaviral Research Unit, Discipline of Immunology and Microbiology, Faculty of Health, The University of Newcastle, David Maddison Clinical Sciences Building, 2300, Newcastle, New South Wales, Australia
286 Viralytics Ltd, Suite 1B, 55-63 Grandview St, 2073, Pymble, New South Wales, Australia
287 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...